Business Context and Reporting Period
This Form 8-K is filed by RYVYL Inc. (RVYL) on June 10, 2025, reporting events occurring between June 10 and June 13, 2025. The company is a Nevada corporation listed on the Nasdaq Capital Market. The filing addresses critical listing compliance issues, board composition changes, and updates regarding a pending asset sale and strategic pivot.
Key Financial Metrics and Liquidity
The filing does not provide current revenue, profit, or cash flow figures for the reporting period. However, it references historical financial data relevant to listing compliance:
- Stockholders' Equity: Reported as a deficit of ($1,492,000) as of December 31, 2024, which triggered noncompliance with Nasdaq's $2.5 million minimum equity requirement.
- Stock Price: The closing bid price fell below $1.00 per share for 30 consecutive business days, triggering noncompliance with Nasdaq Listing Rule 5550(a)(2).
- Pending Transaction: A Stock Purchase Agreement (SPA) dated January 23, 2025, involves the sale of Ryvyl (EU) EAD shares for an aggregate purchase price of $15,000,000.
Material Changes and Listing Status
The company faces two distinct Nasdaq listing deficiencies:
- Minimum Bid Price: Received notice on June 12, 2025, of noncompliance due to stock price below $1.00. The company has an initial 180-day compliance period ending December 9, 2025, to regain compliance (price must exceed $1.00 for 10 consecutive business days).
- Minimum Stockholders' Equity: Previously notified on April 8, 2025, of noncompliance due to negative equity. A compliance plan was submitted on May 21, 2025, and accepted by Nasdaq, granting an extension to evidence compliance.
Guidance, Outlook, and Management Commentary
Strategic Pivot and Acquisition: Management is pursuing an "Enhanced Business Plan" contingent on the sale of Ryvyl EU. The company has entered a non-binding Letter of Intent (LOI) to acquire an entity with complementary technology and digital assets. This plan is conditional on raising a minimum of $100 million, which may require shareholder approval for a reverse stock split and an increase in authorized common stock.
Liability Release: On June 13, 2025, the company received confirmation that its obligation to pay damages (previously up to $16.5 million) under the SPA for the Ryvyl EU sale has ceased to apply.
Board Changes: David Montoya resigned as a Director effective June 10, 2025. Brett Moyer was appointed as a Director and member of the Audit, Compensation, and Nominating Committees on June 12, 2025.
Risks: The filing highlights significant risks including potential delisting if compliance is not met, failure to secure the $100 million financing, and the uncertainty of closing the proposed acquisition.
Investor Verification Checklist
- Verify the status of the $15 million Ryvyl EU sale and whether the transaction has closed.
- Monitor the stock price to ensure it meets the $1.00 threshold for 10 consecutive days before December 9, 2025, to avoid delisting.
- Confirm the progress of the $100 million fundraising required for the proposed acquisition and reverse stock split.
- Review the definitive terms of the non-binding LOI for the new technology acquisition.
- Check for any updates on the company's plan to cure the negative stockholders' equity deficit.